Skip to content

MBX Biosciences

US · MBX #2567 by market cap Listed 2024
49.55 -3.86 -7.23%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 6 analysts

Buy
Avg price target 98.33 +98.4%
Price target rangecurrent 49.55
Low84.00
Avg98.33
High150.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-12 H.C. Wainwright -- Buy 90.00
2026-11-10 UBS -- Buy 90.00
2026-11-10 Stifel -- Buy 84.00
2026-10-13 Barclays -- Buy 88.00
2026-10-12 Stifel -- Buy 84.00
2026-10-12 Guggenheim -- Buy 150.00
2026-10-02 Guggenheim -- Buy 150.00
2026-08-21 J.P. Morgan -- Buy 88.00
2026-08-11 Stifel -- Buy 70.00
2026-08-10 Truist Financial -- Buy 88.00
2026-08-08 LifeSci Capital -- Buy 121.00
2026-08-07 Barclays -- Buy 88.00
2026-08-06 LifeSci Capital -- Buy 121.00
2026-07-24 UBS -- Buy 90.00
2026-07-23 UBS -- Buy 90.00
2026-07-15 Truist Financial -- Buy --
2026-07-14 LifeSci Capital -- Buy 91.00
2026-07-14 Guggenheim -- Buy 88.00
2026-06-18 LifeSci Capital -- Buy 91.00
2026-06-15 Truist Financial -- Buy 70.00
2026-06-15 Guggenheim -- Buy 88.00
2026-06-15 Barclays -- Buy 70.00
2026-06-13 LifeSci Capital -- Buy 91.00
2026-06-12 LifeSci Capital -- Buy 91.00
2026-06-11 Truist Financial -- Buy --

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

MBX Biosciences discussion 0 comments

Add a comment